Announcements
Neville Registrars welcomes Elecosoft plc
Neville Registrars is delighted to welcome Elecosoft plc as the newest addition to its list of client companies.
Elecosoft provides integrated software and associated services to the worldwide architectural, engineering, construction and owner/operator (AECO) industries.
Further information can be found on the Company's website: https://www.elecosoft.com/
Midatech Pharma PLC : MTX102 Safety Results
RNS Number : 0503G
Midatech Pharma PLC
19 July 2019
19 July 2019
Midatech Pharma PLC
("Midatech" or the "Company")
Midatech Announces Safety Results from First in Human Study for Injectable MidaCore® Gold Nano Particle Diabetes Vaccine Programme - MTX102
Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP)
Cadence Minerals PLC : Update - Yangibana - Hastings Technology Metals
RNS Number : 8248F
Cadence Minerals PLC
17 July 2019
Cadence Minerals Plc
("Cadence Minerals", "Cadence" or "the Company")
Hastings Technology Metals (ASX:HAS) Confirms No Appeals on EPA Recommendation of Environmental Approval for Proposal to Mine & Process Rare Earths at Yangibana.
Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pl
Neville Registrars at The ICSA Annual Conference 2019
Neville Registrars is pleased to announce that it will be exhibiting at The ICSA Annual Conference 2019 to be held on the 9th & 10th July (8.30am - 5.30pm) at the ExceL Conference Centre, London.
Please find us at Stand 31 where we will be delighted to discuss your Company's requirements and outline the numerous services/products we can offer.
ValiRx PLC : Update re VAL301
RNS Number : 4280E
ValiRx PLC
04 July 2019
VALIRX PLC
("ValiRx", the "Company" or the "Group")
UPDATE RE VAL301
FOR THE TREATMENT OF ENDOMETRIOSIS
"ValiRx progresses VAL301 Clinical Development Plan"
London, UK., 04 July 2019: ValiRx Plc (AI
Midatech Pharma PLC : MTX110 Update
RNS Number : 3368E
Midatech Pharma PLC
03 July 2019
3 July 2019
Midatech Pharma PLC
("Midatech" or the "Company")
MTX110 Update
Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), the R&D company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce an update on its
Crimson Tide PLC : Contract Wins and New Partnerships
RNS Number : 5668D
Crimson Tide PLC
27 June 2019
Crimson Tide plc
("Crimson Tide" or "the Company")
Contract Wins and New Partnerships
Crimson Tide is pleased to report a number of contract wins for its mpro5 platform as well as new partnership agreements.
In the Middle East, the Company has won an mpro5 contract through their newly appo
Bidstack Group PLC : Results of Independent Study by Lumen Research
RNS Number : 2399D
Bidstack Group PLC
24 June 2019
RNS Reach
24 June 2019
Bidstack Group PLC ("Bidstack" or "the Company")
Results of Independent Study by Lumen Research
Bidstack Group plc (AIM: BIDS.L), the native in-game advertising group, is pleased to announce the results of an independent study commissioned by Bidstack which used eye tracking techno
ValiRx PLC : Update on VAL201 Clinical Trial
RNS Number : 8083C
ValiRx PLC
20 June 2019
VALIRX PLC
("ValiRx" or the "Company")
CLINICAL UPDATE
MHRA and REC approve a major update to the trial of VAL201 including the appointment of a Principle Investigator to the clinical team
Results from the first clinical trial of VAL201 are bein
Neville Registrars welcomes Libero Pharma Limited
Neville Registrars is delighted to welcome Libero Pharma Limited as the newest addition to its list of client companies.
